Adenosine deaminases acting on RNA (ADARs) are enzymes related in RNA editing that converts adenosine residues to inosine specifically in double-stranded RNAs. ADAR regulates mRNA stability and gene expression. ADAR1-Dicer complexes promote microRNA processing and RNA interference (RNAi) gene silencing. ADAR1 is highly expressed in human pluripotent stem cells. Recently, we observed that ADAR1-deficiency in human iPS cells promotes caspase3-mediated apoptotic cell death. On the other hand, ADAR1-deficiency did not alter cell morphology, alkaline phosphatase (AP) staining activities and the expression levels of pluripotent marker genes, indicating that ADAR1 is not required for maintenance of pluripotency. Further, ADAR1 deficient iPS cells did not change proliferation rate. Altogether, we demonstrated that ADAR1 is necessary for existence of human iPS cells.
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Adenosine deaminase acting on RNAs (ADARs) are enzymes which convert adenosine to inosine in double-strand RNAs. ADAR regulates mRNA stability and gene expression through HuR [1] . ADAR1-Dicer complexes promote microRNA processing and RNA interference (RNAi) gene silencing [2] . The deficiency of ADAR1 leads to an embryonic lethality at E11.0-12.5 because of widespread apoptosis in many tissues [3, 4] . ADAR1 is necessary for embryo development by disrupting stress-induced apoptosis. ADAR1+/-ES cells did not exhibit any obvious alteration in their morphology or growth [5] . All teratomas derived from these ES cells contained a variety of differentiated and undifferentiated tissues but with an abundance of cells of neuronal origin (70 to 90%) [5] . ADAR1 is highly expressed in human pluripotent stem cells. However, the functional roles of ADAR1 in human iPS cells had not yet been analyzed and reported.
In order to analyze functional roles of ADAR1 in human iPS cells, we performed knockdown experiments and evaluated the quality as pluripotent stem cells [6] . ADAR1 deficient iPS cells show a remarkably repressed cell number. We tested whether ADAR1-deficiency inhibit cell proliferation or reduce cell viability. Ki67 staining confirmed that ADAR1-deficiency is not influenced on cell proliferation. MTT assay revealed that ADAR1-deficiency reduces cell viability. These results indicate that the number of ADAR1 deficient human iPS cells is repressed by reducing cell viability and not by inhibition of cell division.
To determine whether reduction in cell viability after ADAR1-deficiency was due to induction of apoptosis, apoptotic assays were performed [6] . Annexin V staining assay revealed that remarkable increase in number of apoptotic cells. Caspase3 staining showed that remarkable increase in number of apoptotic cells. Altogether, loss of ADAR1 promotes caspase3-mediated cell death.
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ADAR1-deficiency did not alter cell morphology, alkaline phosphatase (AP) staining activities and the expression levels of pluripotent marker genes, indicating that ADAR1 is not required for maintenance of pluripotency [6] . Furthermore, in vitro differentiation assay revealed that ADAR1 deficient iPS cells could differentiate into three germ layers in vitro [6] .
Poor survivals of human ES cells are observed after cell dissociation. Dissociated human ES cells treated with Rock inhibitor Y-27632 is protected from apoptosis [7, 8] . Y-27632 treatment could not rescue caspase3-mediated cell death in ADAR1 deficient iPS cells. Thus, ADAR1 deficiency is not involved in activation of Abr-Rho pathway triggered by impaired cell-cell contact.
Our study showed that ADAR1 in human iPS cells is necessary for existence of human iPS cells.
